Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
JAMA Oncology|May 28, 2021
Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in JapanShu Yazaki, Tatsuya Yoshida, Yuki Kojima, et al.Breast Cancer Research and Treatment|November 17, 2022
Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapyShu Yazaki, Tatsunori Shimoi, Masayuki Yoshida, et al.Cancer Cell International|February 4, 2023
Changes in HER3 expression profiles between primary and recurrent gynecological cancersYuki Kojima, Kazuki Sudo, Hiroshi Yoshida, et al.Cancer Medicine|August 4, 2023
Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosisKengo Hiranuma, Yuka Asami, Mayumi Kobayashi Kato, et al.Frontiers in Oncology|April 13, 2023
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancerTomomi Sanomachi, Hitomi Sumiyoshi Okuma, Rui Kitadai, et al.Cancer Research Communications|July 12, 2023
Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase IbHanae Ida, Toshio Shimizu, Makoto Nishino, et al.Breast Cancer (Tokyo, Japan)|January 3, 2021
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)Takamichi Yokoe, Sasagu Kurozumi, Kazuki Nozawa, et al.Journal for Immunotherapy of Cancer|May 11, 2025
The cold immunological landscape of ATM-deficient cancersSonali Sinha, Victor Ng, Ardijana Novaj, et al.Breast Cancer : Basic and Clinical Research|November 4, 2024
Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY StudyMomoko Tokura, Mark Malalay Ando, Yuki Kojima, et al.Cancer Science|February 11, 2025
Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast CancerRui Kitadai, Shu Yazaki, Aya Kuchiba, et al.Pageof 4